MCK

McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date

Retrieved on: 
Wednesday, March 27, 2024

McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024.

Key Points: 
  • McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024.
  • The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
  • The live webcast will be available on McKesson’s Investor Relations website at http://investor.mckesson.com , along with the company’s earnings release, financial tables and slide presentation.

Cornerstone AI Taps Viraj Narayanan as Co-CEO to Drive Industry-wide Adoption of Clean Data in Healthcare and Pharmaceuticals

Retrieved on: 
Thursday, April 4, 2024

SAN FRANCISCO, April 4, 2024 /PRNewswire-PRWeb/ -- Cornerstone AI, makers of a powerful AI software solution that cleans real world healthcare data significantly faster and more accurately than existing solutions, today announced that Viraj Narayanan has joined the company as Co-CEO. Narayanan will work alongside Cornerstone AI founder and Co-CEO Michael Elashoff to scale its highly intelligent, automated software platform which has created unparalleled efficiencies while enabling confidence in the fidelity of data needed to answer critical scientific questions.

Key Points: 
  • "Cornerstone will become the leading utility for data cleaning ," said Narayanan.
  • "Everyone is learning how AI can help organizations run more efficiently than ever before, but in healthcare, nailing the data piece is essential."
  • "We've built a remarkably robust platform to clean healthcare data at scale, without sacrificing the precision and accuracy required in life sciences," said Elashoff.
  • "Now is the time that pharmaceutical companies need to access the insights in Real World Data.

McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance

Retrieved on: 
Wednesday, February 7, 2024

McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results.

Key Points: 
  • McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results.
  • Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results .
  • As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 7th at 4:30 PM ET to review its financial results.
  • The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company’s earnings press release, financial tables, and slide presentation.

McKesson Corporation Declares Quarterly Dividend

Retrieved on: 
Thursday, February 1, 2024

The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on April 1, 2024, to stockholders of record on March 1, 2024.

Key Points: 

The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on April 1, 2024, to stockholders of record on March 1, 2024.

McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Tuesday, January 9, 2024

McKesson Corporation (NYSE: MCK) will present at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT (12:45 PM ET).

Key Points: 
  • McKesson Corporation (NYSE: MCK) will present at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT (12:45 PM ET).
  • The audio webcast will be available live at McKesson’s Investor Relations website at investor.mckesson.com , along with the company’s slide presentation.
  • The McKesson board of directors has elected Kevin Ozan as director and member of the Audit Committee and Finance Committee, effective January 8, 2024.
  • On January 4, 2024, McKesson acquired Compile, a healthcare data platform that aggregates and integrates data from across the US healthcare system to characterize providers and their patient panels.

McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference

Retrieved on: 
Wednesday, December 27, 2023

McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024.

Key Points: 
  • McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024.
  • The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
  • McKesson management will be participating in the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024.
  • The live webcast for each event will be available on McKesson’s Investor Relations website at http://investor.mckesson.com , along with the company’s earnings release, financial tables and slide presentation.

McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance

Retrieved on: 
Wednesday, November 1, 2023

McKesson Corporation (NYSE: MCK) has released its fiscal 2024 second quarter financial results.

Key Points: 
  • McKesson Corporation (NYSE: MCK) has released its fiscal 2024 second quarter financial results.
  • Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results .
  • As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, November 1st at 4:30 PM ET to review its financial results.
  • The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company’s earnings press release, financial tables, and slide presentation.

McKesson Corporation Declares Quarterly Dividend

Retrieved on: 
Thursday, October 26, 2023

The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on January 2, 2024, to stockholders of record on December 1, 2023.

Key Points: 

The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on January 2, 2024, to stockholders of record on December 1, 2023.

KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors

Retrieved on: 
Wednesday, October 4, 2023

"I am extremely proud to welcome a highly accomplished executive such as Ed to our Board of Directors.

Key Points: 
  • "I am extremely proud to welcome a highly accomplished executive such as Ed to our Board of Directors.
  • Edward Wholihan joins KORU Medical's Board of Directors with over 25 years of experience as Chief Financial Officer driving growth and shareholder value for public, private equity-sponsored, and venture capital-funded life sciences and healthcare businesses.
  • He earned his MBA from Stanford University's Graduate School of Business and a BA in economics from Yale University.
  • "I look forward to supporting Linda and the KORU Medical team as they continue to drive the Company’s growth strategy and the provision of subcutaneous infusion therapies and their benefits to patients."

Gentherm Announces Dr. Ken Washington as New Independent Director

Retrieved on: 
Monday, October 2, 2023

He was appointed to this position in June 2023, and he leads innovation and the expansion of technology platforms across Medtronic’s portfolio.

Key Points: 
  • He was appointed to this position in June 2023, and he leads innovation and the expansion of technology platforms across Medtronic’s portfolio.
  • At Amazon Lab 126, Dr. Washington was responsible for all aspects of the profitability of Amazon’s consumer robotics business unit.
  • Dr. Washington worked at Lockheed Martin Corporation as Vice President of the Advanced Technology Center and its first Chief Privacy Officer.
  • Dr. Washington also served for approximately 21 years in various roles at Sandia National Laboratories, including as Chief Information Officer.